Patents by Inventor Marcel Leist

Marcel Leist has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF SIRAMESINE IN THE TREATMENT OF CANCER
    Publication number: 20090203721
    Abstract: The present invention relates to the treatment of cancer. In particular, the invention provides pharmaceutical compositions comprising siramesine for the treatment of cancer. The invention further provides a method of treatment comprising administering siramesine to a patient suffering from cancer.
    Type: Application
    Filed: April 20, 2009
    Publication date: August 13, 2009
    Applicant: H. Lundbeck A/S
    Inventors: Christian Thomsen, Marcel Leist, Marja Jaattela, Marie Stampe Ostenfeld
  • Use of siramesine in the treatment of cancer
    Publication number: 20060178389
    Abstract: The present invention relates to the treatment of cancer. In particular, the invention provides pharmaceutical compositions comprising siramesine for the treatment of cancer. The invention further provides a method of treatment comprising administering siramesine to a patient suffering from cancer.
    Type: Application
    Filed: December 21, 2005
    Publication date: August 10, 2006
    Inventors: Christian Thomsen, Marcel Leist, Marja Jaattela, Marie Ostenfeld
  • Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds
    Publication number: 20040214236
    Abstract: The present invention is directed methods for identifying compounds that have a tissue protective activity using a heteromultimer receptor complex that mediates the tissue protective activities. The complex consists of at least one EPO-R in complex with at least one &bgr;c Receptor. These compounds used in the assays to identify tissue protective compounds include, but are not limited to, small molecules and biologics. The compounds identified using these assays can be used to treat various conditions of the central and peripheral nervous systems as well as those of other erythropoietin-responsive or excitable cells, tissues, and organs.
    Type: Application
    Filed: September 30, 2003
    Publication date: October 28, 2004
    Inventors: Michael Brines, Anthony Cerami, Pietro Ghezzi, Fabio Fiordaliso, Maddalena Fratelli, Marcel Leist, Mette Nielsen, Thomas Sager, Jens Gerwien, Lars Ostergaard Pedersen
  • Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs
    Publication number: 20040122216
    Abstract: Methods and compositions are provided for protecting or enhancing a responsive cell, tissue, organ or body part function or viability in vivo, in situ or ex vivo in mammals, including human beings, by systemic or local administration of an erythropoietin receptor activity modulator, such as an recombinant tissue protective cytokine.
    Type: Application
    Filed: July 1, 2003
    Publication date: June 24, 2004
    Inventors: Jacob Nielsen, Jan Torleif Pedersen, Jens Gerwien, Katrine Bay, Lars Ostergaard Pedersen, Marcel Leist, Marie Aavang Geist, Pekka Kallunki, Soren Christensen, Thomas Sager, Michael Brines, Anthony Cerami, Carla Cerami